These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18450045)

  • 1. Basic principles of statistical inference.
    Tu W
    Methods Mol Biol; 2007; 404():53-72. PubMed ID: 18450045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidence interval construction for a difference between two dependent intraclass correlation coefficients.
    Ramasundarahettige CF; Donner A; Zou GY
    Stat Med; 2009 Mar; 28(7):1041-53. PubMed ID: 19142855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical inference by confidence intervals: issues of interpretation and utilization.
    Sim J; Reid N
    Phys Ther; 1999 Feb; 79(2):186-95. PubMed ID: 10029058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notes on testing non-inferiority under the partial verification design with a confirmatory procedure limited to screen positives.
    Lui KJ
    Contemp Clin Trials; 2012 May; 33(3):563-71. PubMed ID: 22366778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized P-values and confidence intervals: a novel approach for analyzing lognormally distributed exposure data.
    Krishnamoorthy K; Mathew T; Ramachandran G
    J Occup Environ Hyg; 2006 Nov; 3(11):642-50. PubMed ID: 17086669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferences on the common coefficient of variation.
    Tian L
    Stat Med; 2005 Jul; 24(14):2213-20. PubMed ID: 15803444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical considerations for the design and analysis of Phase III clinical trials in prostate cancer.
    Halabi S
    Urol Oncol; 2008; 26(3):300-7. PubMed ID: 18452825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical inference on categorical variables.
    Perkins SM
    Methods Mol Biol; 2007; 404():73-88. PubMed ID: 18450046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating statistical difference, equivalence, and indeterminacy using inferential confidence intervals: an integrated alternative method of conducting null hypothesis statistical tests.
    Tryon WW
    Psychol Methods; 2001 Dec; 6(4):371-86. PubMed ID: 11778678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random assignment of available cases: bootstrap standard errors and confidence intervals.
    Lunneborg CE
    Psychol Methods; 2001 Dec; 6(4):402-12. PubMed ID: 11778680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect size, confidence interval and statistical significance: a practical guide for biologists.
    Nakagawa S; Cuthill IC
    Biol Rev Camb Philos Soc; 2007 Nov; 82(4):591-605. PubMed ID: 17944619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL
    Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical estimates and clinical trials.
    Braitman LE
    J Biopharm Stat; 1993 Sep; 3(2):249-56. PubMed ID: 8220407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.
    Kosinski AS; Chen Y; Lyles RH
    Stat Med; 2010 Jul; 29(15):1572-9. PubMed ID: 20552570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical versus statistical significance: interpreting P values and confidence intervals related to measures of association to guide decision making.
    Ferrill MJ; Brown DA; Kyle JA
    J Pharm Pract; 2010 Aug; 23(4):344-51. PubMed ID: 21507834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical methods for evaluating multiple sclerosis therapies.
    Petkau J
    Semin Neurol; 1998; 18(3):351-75. PubMed ID: 9817539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence interval for statistical power using a sample variance estimate.
    Liu X
    Nurse Res; 2013; 21(1):40-6. PubMed ID: 24004431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer.
    Dvorak T; Chen MH; Renshaw AA; Loffredo M; Richie JP; D'Amico AV
    Urology; 2005 Nov; 66(5):1024-8. PubMed ID: 16286117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.